RPID — Rapid Micro Biosystems Cashflow Statement
0.000.00%
Last trade - 00:00- $136.17m
- $105.12m
- $28.05m
- 15
- 23
- 41
- 15
Annual cashflow statement for Rapid Micro Biosystems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -37.1 | -73.5 | -60.8 | -52.5 | -46.9 |
| Depreciation | |||||
| Non-Cash Items | 5.67 | 25 | 4.75 | 3.73 | 4.14 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.1 | -8 | -5.33 | 0.555 | -4.77 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -31 | -55 | -58.5 | -45.1 | -44.2 |
| Capital Expenditures | -0.69 | -3.22 | -6.74 | -1.84 | -1.36 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -15 | -10.1 | -86.7 | 44 | 38 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -15.7 | -13.3 | -93.5 | 42.2 | 36.7 |
| Financing Cash Flow Items | -2.27 | -1.34 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 64.2 | 217 | 0.693 | 0.149 | 0.203 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.6 | 148 | -151 | -2.78 | -7.29 |